Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 352130, 10 pages
http://dx.doi.org/10.1155/2013/352130
Review Article

Astragalus in the Prevention of Upper Respiratory Tract Infection in Children with Nephrotic Syndrome: Evidence-Based Clinical Practice

Nephrology Center, Guangdong Provincial Hospital of Chinese Medicine, No. 111 Dade Road, Guangzhou, Guangdong Province 510120, China

Received 30 October 2012; Revised 18 February 2013; Accepted 25 February 2013

Academic Editor: Taixiang Wu

Copyright © 2013 Chuan Zou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. McIntyre and J. C. Craig, “Prevention of serious bacterial infection in children with nephrotic syndrome,” Journal of Paediatrics and Child Health, vol. 34, no. 4, pp. 314–317, 1998. View at Google Scholar · View at Scopus
  2. P. F. Du, S. R. Zhu, and G. P. Wang, “An analysis for nosocomial infection in primary nephrotic syndrome—a report of 125 cases,” Chinese Journal of Clinical Pediatrics, vol. 14, no. 1, pp. 35–36, 1996. View at Google Scholar
  3. Q. Y. Wu and X. Wu, “Clinical study of gammaglobulin on upper respiratory infection prevention in nephrotic syndrome children,” Journal of Hainan Medical College, vol. 15, no. 8, pp. 879–880, 2009. View at Google Scholar
  4. B. Wu and N. F. Xu, “Clinical epidemiology study on risk factors for nosocomial infection in children with nephrotic syndrome,” Chinese Journal of Nosocomiology, vol. 10, no. 3, pp. 34–35, 2000. View at Google Scholar
  5. N. E. MacDonald, N. Wolfish, P. McLaine, P. Phipps, and E. Rossier, “Role of respiratory viruses in exacerbations of primary nephrotic syndrome,” Journal of Pediatrics, vol. 108, no. 3, pp. 378–382, 1986. View at Google Scholar · View at Scopus
  6. A. A. S. L. Safaei and S. Maleknejad, “Clinical and laboratory findings and therapeutic responses in children with nephrotic syndrome,” Indian Journal of Nephrology, vol. 20, no. 2, pp. 68–71, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Sumboonnanonda, N. Chongchate, V. Suntornpoch, A. Pattaragarn, and S. Supavekin, “Difficult-to-treat nephrotic syndrome: management and outcome,” Journal of the Medical Association of Thailand, vol. 88, supplement 8, pp. S142–S148, 2005. View at Google Scholar · View at Scopus
  8. R. K. Alwadhi, J. L. Mathew, and B. Rath, “Clinical profile of children with nephrotic syndrome not on glucorticoid therapy, but presenting with infection,” Journal of Paediatrics and Child Health, vol. 40, no. 1-2, pp. 28–32, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Gulati, A. Sinha, V. Sreenivas, A. Math, P. Hari, and A. Bagga, “Daily corticosteroids reduce infection-associated relapses in frequently relapsing nephrotic syndrome: a randomized controlled trial,” Clinical Journal of the American Society of Nephrology, vol. 6, no. 1, pp. 63–69, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. A. S. Abeyagunawardena and R. S. Trompeter, “Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial,” Archives of Disease in Childhood, vol. 93, no. 3, pp. 226–228, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Wu, Z. Wang, and D. Wang, “Respiratory virus expression in renal tissues and urine of children with steroid responsive simple nephrotic syndrome,” Journal of Sichuan University (Medical Science Edition), vol. 38, no. 6, pp. 969–972, 2007. View at Google Scholar · View at Scopus
  12. A. A. Eddy and J. M. Symons, “Nephrotic syndrome in childhood,” The Lancet, vol. 362, no. 9384, pp. 629–639, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Shroff, R. Frank, M. Vergara, B. Gauthier, and H. Trachtman, “Prevention of serious bacterial infections in new-onset nephrotic syndrome: a survey of current practices,” Clinical Pediatrics, vol. 41, no. 1, pp. 47–49, 2002. View at Google Scholar · View at Scopus
  14. H. M. Wu, J. L. Tang, L. Cao, Z. H. Sha, and Y. Li, “Interventions for preventing infection in nephrotic syndrome,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD003964, 2012. View at Publisher · View at Google Scholar
  15. K. I. Block and M. N. Mead, “Immune system effects of echinacea, ginseng, and astragalus: a review,” Integrative Cancer Therapies, vol. 2, no. 3, pp. 247–267, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. W. Yuan, J. Wang, and T. Wu, “Chinese herbal medicine Huangqi type formulations for nephrotic syndrome,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD006335, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. G. G. Kang, “Preventive effects of Huangqi on secondary infection in children with simple nephrotic syndrome,” Chinese Journal of Integrated Traditional and Western Nephrology, vol. 6, no. 12, pp. 718–719, 2005. View at Google Scholar
  18. J. Chen and S. Q. Chen, “Preventive effects of Huangqi on infection in children with nephrotic syndrome,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 28, no. 5, pp. 467–469, 2008. View at Google Scholar
  19. X. L. Xie and Y. Peng, “Preventive effect of Huangqi in refractory infection of nephrotic syndrome,” Hubei Journal of Traditional Chinese Medicine, vol. 32, no. 05, pp. 9–10, 2010. View at Google Scholar
  20. J. Zhang and Y. Zhang, “Treatment effects of Huangqi granules on nephrotic syndrome and its secondary infection,” Chinese Journal of Traditional Chinese Medicine, vol. 23, no. 09, pp. 846–847, 2008. View at Google Scholar
  21. H. Z. Yuan, F. Xie, and C. T. Zhang, “The effect of Huangqi and red Chinese date in the process of corticosterone reduction in refractory primary nephrotic syndrome with mesangial proliferative glomerulonephritis,” Chinese Journal of Integrated Medicine, vol. 5, no. 7, pp. 413–414, 2004. View at Google Scholar
  22. L. A. Barness, G. H. Moll, and C. A. Janeway, “Nephrotic syndrome I. Natural history of the disease,” Pediatrics, vol. 5, no. 3, pp. 486–503, 1950. View at Google Scholar
  23. D. Lawson, A. Moncrieff, and W. W. Payne, “Forty years of nephrosis in childhood,” Archives of disease in childhood, vol. 35, pp. 115–126, 1960. View at Google Scholar · View at Scopus
  24. G. Arneil, “164 children with nephrosis,” The Lancet, vol. 278, no. 7212, pp. 1103–1110, 1961. View at Google Scholar · View at Scopus
  25. “Minimal change nephrotic syndrome in children: deaths during the first 5 to 15 years' observation. Report of the international study of kidney disease in children,” Pediatrics, vol. 73, no. 4, pp. 497–501, 1984.
  26. J. Giangiacomo, T. G. Cleary, and B. R. Cole, “Serum immunoglobulins in the nephrotic syndrome. A possible cause of minimal change nephrotic syndrome,” The New England Journal of Medicine, vol. 293, no. 1, pp. 8–12, 1975. View at Google Scholar · View at Scopus
  27. J. S. Spika, N. A. Halsey, A. J. Fish et al., “Serum antibody response to pneumococcal vaccine in children with nephrotic syndrome,” Pediatrics, vol. 69, no. 2, pp. 219–223, 1982. View at Google Scholar · View at Scopus
  28. R. H. McLean, A. Forsgren, B. Björkstén, Y. Kim, P. G. Quie, and A. F. Michael, “Decreased serum factor B concentration associated with decreased opsonization of Escherichia coli in the idiopathic nephrotic syndrome,” Pediatric Research, vol. 11, no. 8, pp. 910–916, 1977. View at Google Scholar · View at Scopus
  29. M. Ballow, T. L. Kennedy, K. M. Gaudio, N. J. Siegel, and R. H. McLean, “Serum hemolytic factor D values in children with steroid-responsive idiopathic nephrotic syndrome,” Journal of Pediatrics, vol. 100, no. 2, pp. 192–196, 1982. View at Google Scholar · View at Scopus
  30. Q. F. Nie and P. Yi, “Huangqi on SIL-2R, IL-8 and Ig in refractory respiratory infection patients,” Journal of Cellular and Molecular Immunology, vol. 4, pp. 362–363, 2009. View at Google Scholar
  31. H. Kiyohara, T. Nagai, K. Munakata et al., “Stimulating effect of Japanese herbal (Kampo) medicine, Hochuekkito on upper respiratory mucosal immune system,” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 4, pp. 459–467, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. D. T. Chu, W. L. Wong, and G. M. Mavligit, “Immunotherapy with Chinese medicinal herbs. II. Reversal of cyclophosphamide-induced immune suppression by administration of fractionated Astragalus membranaceus in vivo,” Journal of Clinical and Laboratory Immunology, vol. 25, no. 3, pp. 125–129, 1988. View at Google Scholar · View at Scopus
  33. K. S. Zhao, C. Mancini, and G. Doria, “Enhancement of the immune response in mice by Astragalus membranaceus extracts,” Immunopharmacology, vol. 20, no. 3, pp. 225–233, 1990. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Peng, Y. Yang, H. Riesemann, and R. Kandolf, “The inhibitory effect of Astragalus membranaceus on coxackie B-3 virus RNA replication,” Chinese Medical Sciences Journal, vol. 10, no. 3, pp. 146–150, 1995. View at Google Scholar · View at Scopus
  35. A. L. Miller, “Botanical influences on cardiovascular disease,” Alternative Medicine Review, vol. 3, no. 6, pp. 422–431, 1998. View at Google Scholar · View at Scopus
  36. J. L. Tang, S. Y. Zhan, and E. Ernst, “Review of randomised controlled trials of traditional Chinese medicine,” The British Medical Journal, vol. 318, no. 7203, pp. 160–161, 1999. View at Google Scholar · View at Scopus
  37. J. Thornton, P. Alderson, T. Tan et al., “Introducing GRADE across the NICE clinical guideline program,” Journal of Clinical Epidemiology, vol. 66, no. 2, pp. 124–131, 2013. View at Publisher · View at Google Scholar
  38. G. H. Guyatt, A. D. Oxman, R. Kunz et al., “GRADE: going from evidence to recommendations,” The British Medical Journal, vol. 336, no. 7652, pp. 1049–1051, 2008. View at Google Scholar · View at Scopus
  39. M. Brunetti, I. Shemilt, S. Pregno et al., “Grade guidelines: 10. Considering resource use and rating the quality of economic evidence,” Journal of Clinical Epidemiology, vol. 66, no. 2, pp. 140–150, 2013. View at Publisher · View at Google Scholar